您的购物车当前为空
SIRT2-IN-9 是一种具有选择性的SRIT2抑制剂,IC50值为 1.3 μM。SIRT2-IN-9对MCF-7 乳腺癌细胞的增殖有抑制作用。SIRT2-IN-9 可用于研究癌症。


为众多的药物研发团队赋能,
让新药发现更简单!
SIRT2-IN-9 是一种具有选择性的SRIT2抑制剂,IC50值为 1.3 μM。SIRT2-IN-9对MCF-7 乳腺癌细胞的增殖有抑制作用。SIRT2-IN-9 可用于研究癌症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 269 | In Stock | |
| 5 mg | ¥ 633 | In Stock | |
| 10 mg | ¥ 1,080 | In Stock | |
| 25 mg | ¥ 2,230 | In Stock | |
| 50 mg | ¥ 3,630 | In Stock | |
| 100 mg | ¥ 5,230 | In Stock |
SIRT2-IN-9 相关产品
| 产品描述 | SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research. |
| 靶点活性 | SIRT2:1.3 μM, SIRT3:>300 μM, SIRT1:>300 μM |
| 体外活性 | SIRT2-IN-9(1-100 μM;15分钟)对SRIT2具有剂量依赖性的抑制作用(IC50=1.3 μM),同时对SRIT1和SRIT3的抑制作用较弱(IC50s>300 μM)。[1] 在MCF-7细胞上,SIRT2-IN-9(0-50 μM;72小时)影响细胞活力,并剂量依赖性地抑制MCF-7乳腺癌细胞的增殖。[1] 此外,SIRT2-IN-9(0-50 μM;6小时)影响α-微管蛋白的乙酰化水平。[1] |
| 分子量 | 438.57 |
| 分子式 | C21H22N6OS2 |
| CAS No. | 522650-91-5 |
| Smiles | CCCn1c2ccccc2c2nnc(SCC(=O)Nc3nc4CCCCc4s3)nc12 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| 溶解度信息 | DMSO: 4.0 mg/mL (9.2 mM), Sonication and heating to 70℃ are recommended. | |||||||||||||||
溶液配制表 | ||||||||||||||||
DMSO
| ||||||||||||||||
评论内容